CytoDyn (CYDY) SEC Filings & 10K Form $0.30 +0.05 (+20.04%) As of 02/21/2025 03:59 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Recent CytoDyn SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView01/14/20254:15 PMCytoDyn (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 01/14/20254:17 PMCytoDyn (Filer)Form 424B311/22/20244:15 PMCytoDyn (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/30/20248:45 PMBlok Tyler (Reporting)CytoDyn (Issuer)Form 4Statement of changes in beneficial ownership of securities 10/30/20248:45 PMBrunke Karen J (Reporting)CytoDyn (Issuer)Form 4Statement of changes in beneficial ownership of securities 10/30/20248:46 PMCytoDyn (Issuer)Dunlap Ryan (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/30/20248:47 PMCytoDyn (Issuer)Lalezari Jacob P (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/30/20248:47 PMCytoDyn (Issuer)Ndhlovu Lishomwa C (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/30/20248:48 PMCytoDyn (Issuer)SIMES STEPHEN M (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/30/20248:48 PMCytoDyn (Issuer)Urbach Tanya Durkee (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/17/20244:15 PMCytoDyn (Filer)Form 424B3 Get the Latest News and Ratings for CYDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter. 10/15/20244:16 PMCytoDyn (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 10/11/20248:00 AMCytoDyn (Filer)Form DEF 14A10/01/202411:15 PMCytoDyn (Filer)Form EFFECT10/01/20244:15 PMCytoDyn (Filer)Form 424B309/30/20244:01 PMCytoDyn (Filer)Form 10-K/A09/12/202411:15 PMCytoDyn (Filer)Form EFFECT09/12/202411:15 PMCytoDyn (Filer)Form EFFECT09/06/20247:42 PMCytoDyn (Filer)Form S-1Registration statement under Securities Act of 1933 09/06/20247:44 PMCytoDyn (Filer)Form POS AM09/06/20247:44 PMCytoDyn (Filer)Form POS AM08/15/20244:21 PMCytoDyn (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 07/22/20248:00 AMCytoDyn (Subject)Form SC TO-I/A07/09/20244:16 PMCytoDyn (Subject)Form SC TO-I/A07/09/20244:16 PMCytoDyn (Filer)Form 424B307/09/20244:17 PMCytoDyn (Filer)Form 424B307/09/20247:46 AMCytoDyn (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/28/20244:11 PMCytoDyn (Subject)Form SC TO-I/A06/20/20242:16 PMCytoDyn (Subject)Form SC TO-I/A06/03/20244:15 PMCytoDyn (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/06/20244:17 PMCytoDyn (Filer)Form 424B304/16/20244:15 PMCytoDyn (Filer)Form 424B304/16/20244:16 PMCytoDyn (Filer)Form 424B304/15/20244:18 PMCytoDyn (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/08/20244:16 PMCytoDyn (Filer)Form 424B304/08/20244:17 PMCytoDyn (Filer)Form 424B304/08/20247:31 AMCytoDyn (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/28/20244:16 PMCytoDyn (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/08/20248:30 PMCytoDyn (Issuer)Lalezari Jacob P (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/01/20244:15 PMCytoDyn (Filer)Form 424B303/01/20244:16 PMCytoDyn (Filer)Form 424B3Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret.02/22/20244:16 PMCytoDyn (Filer)Form 424B3(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies ELVN 10Q Form CURLF 10Q Form COLL 10Q Form ZYME 10Q Form NTLA 10Q Form COGT 10Q Form REPL 10Q Form PHVS 10Q Form RCKT 10Q Form AVBP 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:CYDY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoDyn Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytoDyn With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.